Navigation Links
KV Pharmaceutical Company Completes Fiscal 2008 Filings With Securities and Exchange Commission
Date:6/25/2008

Company Files Fiscal Form 10-Q's for First Three Quarters of Fiscal 2008

and Form 10-K for Fiscal 2008 Ended March 31, 2008

Points to Positive Fiscal 2009 Outlook for Its Branded and Generic

Pharmaceutical Businesses

ST. LOUIS, June 25 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb), a fully integrated specialty pharmaceutical company that develops, manufactures, acquires and markets technology distinguished branded and generic/non-branded prescription pharmaceutical products, today announced that it has filed Form 10-Q's for the quarters ended June 30, 2007, September 30, 2007 and December 31, 2007, as well as a Form 10-K for its 2008 fiscal year ended March 31, 2008. The financial data included in these filings is consistent with previously reported preliminary financial results.

Marc S. Hermelin, Chairman of the Board and Chief Executive Officer stated, "With the filing of our fiscal 2008 financial reports, the Company is now up to date with its Securities and Exchange Commission filings. Fiscal 2008 was an extraordinary year for KV filled with many accomplishments by both our branded and generic businesses. Our Company continued to perform at record levels despite a difficult industry environment. We fully expect to continue our strong performance in fiscal 2009 and beyond as we execute on our branded and generic strategies and seek to capitalize on our valuable product pipeline."

Mr. Hermelin continued, "As previously reported, KV generated net revenue and net income increases of 36% and 52%, respectively, for fiscal 2008 compared to the prior year. In fiscal 2009 the Company expects to introduce 8-10 new products from Ther-Rx and ETHEX combined, which includes the anticipated approval of six ANDA's and one NDA. The anticipated new products, continued momentum from KV's generic Metoprolol Succinate Extended Release tablets, and expansion of the Company's branded women
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , Study Uses Tent To Simulate ..., Nov. 30 Distance runn...els are known to improve their performance during ...failure patients, who suffer from fatigue, improve...ike, high-altitude simulator? ,, That is the qu...
(Date:11/30/2009)... , NEW YORK, Nov. 30 Of the m...ho are living with HIV/AIDS, nearly half are Afric...s in Washington, D.C. have surpassed the threshold...women account for more than 90 percent of all wome... On Tuesday, December 1 at 6:00 p.m.*, World AIDS ...
(Date:11/30/2009)...a tiny period of time between the registration of ...conscious recognition of it ― between the ti... an apple. Our minds lag behind our eyes, but by h... the world around us? , Some estimates say the...y 500 milliseconds. A new study by Tel Aviv Univer...
(Date:11/30/2009)... Keynote speaker & Author Dr. Te... Corpus Christi, TX (Vocus) No...Conference is set to be held in Corpus Christi fr... 5, 2009 at the American Bank Center., , , , ,The...cted to make a nearly $300,000 economic impact on ...
(Date:11/30/2009)... , NEW YORK, Nov. 30 Reportlin...t is available in its catalogue: ,, Key Player...ging strategies in ingredients, pharma, food and d.../Key-Players-and-Innovative-Start-Ups-in-Nutraceut...od-and-drinks.html ,, Nutraceuticals are bioac...
Breaking Medicine News(10 mins):Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 2Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 3Health News:Now you see it, now you know you see it 2Health News:18th Annual Texas Autism Conference Returns To Corpus Christi, Makes Nearly $300,000 Economic Impact 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 3Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 4Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 6
...D, UCLA Orthopedic Hospital, has been chosen as th...by the Journal of Alzheimers Disease in recognitio...d-beta and inflammation: Two faces of innate immun...e journal select an outstanding article from the p...
...e World Health Organization, nearly three-quarters...irus (HIV)-infected people are living in Sub-Sahar...infected in 2006 caught the virus in this part of ...fected. In contrast to what is observed in other r...
...alif., April 28 IPC The,Hospitalist Company, Inc....oup practice company, announced today that Adam D....present on Tuesday, May 6, 2008 at the,33rd Annual... Event: Deutsche Bank Health Care Conference Dat...
... Crystal Research Associates, LLC,announced today...rview(R),(EIO(R)) on Advaxis, Inc. (OTC Bulletin B...at http://www.crystalra.com ., Advaxis, Inc. ("A... responses against cancer as well as infectious,an...
...6-month Research Project Establishes Effects of Pu...y and Mind, GREENVILLE, N.C. and SEATTLE, April 2...tion and Leisure Studies today revealed,the result...s. The three puzzle and word games used in the stu...
...rweight as they conceive, raising complication ris...lthDay News) -- The number of women starting their...ubled since 1999, but rates of gestational diabete...r of teenagers who had diabetes before birth jumpe...
Other Medicine News:Health News:Milan Fiala, MD, receives 2008 Alzheimer Award 2Health News:Involving partners of pregnant women in Africa to improve AIDS prevention 2Health News:Involving partners of pregnant women in Africa to improve AIDS prevention 3Health News:IPC The Hospitalist Company, Inc. to Present at the 33rd Annual Deutsche Bank Health Care Conference 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Advaxis, Inc. 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Advaxis, Inc. 3Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 2Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 3Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 4Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 5Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 6Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 7Health News:Pre-Pregnancy Diabetes Rates Have Doubled 2Health News:Pre-Pregnancy Diabetes Rates Have Doubled 3
(Date:11/30/2009)...ewswire/ -- Breast-Specific Gamma Imaging (BSGI) h...chnique for the detection of ductal carcinoma in s... BSGI is a molecular breast imaging technique that... discover very early stage cancers. According to f...he Radiological Society of North America (RSNA), B...
(Date:11/30/2009)...Newswire/ -- Breast-Specific Gamma Imaging (BSGI) ...gnant or high-risk lesions in patients with negati...ng to results of a multicenter study presented tod...ty of North America (RSNA). ,, In this retrospe...nostic imaging modality at four institutions and w...
(Date:11/30/2009)...v. 30 Covance Inc. (NYSE...the Piper Jaffray 21st Annual Health Care Conferen...). Investors may access a live webcast of the pre...ter and download any necessary software, please lo...rters in Princeton, New Jersey, is one of the worl...
Breaking Medicine Technology:Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 2BSGI Makes Significant Impact on Detection of Breast Cancer in Patients with Negative Mammographic Findings 2The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide 4568 1The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide 4568 2The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide 4568 3Breast feeding OK for Most Moms with MS 48225 1Breast feeding OK for Most Moms with MS 48225 2Breast feeding OK for Most Moms with MS 48225 3Lack of Sleep Can Raise Blood Pressure Over Time 48223 1Lack of Sleep Can Raise Blood Pressure Over Time 48223 2
...tein Institute for Medical Research have identifie...or rheumatoid arthritis and systemic lupus,erythem...diseases. The genetic link, described in the Sept...cine, was a collaborative effort led by Peter K.,G...bert S. Boas Center for,Genomics & Human Genetics....
...gthened with Clinical Trials Services and...and ATLANTA, Sept. 6 Image Solutions,Inc. (ISI) a...h,Biostatistics, Inc. (ZBI). With the Life Science...bmissions, the acquisition further strengthens,ISI...(CDISC) capabilities,the FDA-supported standard fo...
Other Medicine Technology:New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments 2New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments 3New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments 4Image Solutions, Inc. Acquires Zurich Biostatistics, Inc. 2Image Solutions, Inc. Acquires Zurich Biostatistics, Inc. 3
Motion Graphic Display
72 Frame Eyewear Tower - Silver
...S display system provides maximum impact for the m...ue approach to displaying frames allows your retai...ealing, flexible and eye-catching displays. The pr...re motivated. Removable holders. Variable number o...
Hexagonal Revolving Tower Case
Medicine Products: